{"id":"33bbbf29-0962-43e6-99b5-dd31f1b37095","kind":"news","code":"33bbbf29-0962-43e6-99b5-dd31f1b37095","name":"BioGeometry raises hundreds of millions of RMB in strategic financing","nameBasis":"translated-title","summary":"On 2026-06-09, according to Xiniu Data, BioGeometry completed strategic financing, raising hundreds of millions of RMB. Investors were co-lead investor Shanghai Biotechnology Pharmaceutical Innovation Zhuanhua Fund, co-lead investor Guoke Investment, co-lead investor Dachencaizhi, co-lead investor Xinglian Capital, participating investor Gaorong Capital, participating investor Zhishu Capital. The company is a provider of generative AI protein design platforms.","description":"","country":null,"category":null,"originalName":"百奥几何完成战略投资融资，金额数亿人民币","eventDate":"2026-06-09T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-18T17:08:19.141Z","englishUpdatedAt":"2026-10-20T18:21:37.253Z","reviewedAt":"2026-10-20T18:21:37.253Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"b8881bb2a83bbc21cde17c1a8caf7566e2c459fa131f2a64395f4ba60f336eb9","companyId":"593a5dda-edfd-4e5c-b8af-57df9441389b","foundedYear":null,"logoUrl":null,"originalText":"2026年6月9日，据烯牛数据报道，百奥几何完成战略投资融资，金额数亿人民币。投资方为上海生物医药创新转化基金、国科投资、达晨财智、星连资本领投，高榕资本、指数资本跟投。该公司为生成式AI蛋白质设计平台提供商。","sources":[],"related":[{"id":"593a5dda-edfd-4e5c-b8af-57df9441389b","kind":"companies","code":"UB-C7957","name":"BioGeometry","nameBasis":"source-english","summary":"Protein foundation models and AI biomolecular design","description":"","country":"China","category":null,"originalName":"百奥几何","eventDate":null,"website":"https://www.biogeom.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:24:40.681Z","reviewedAt":"2026-10-20T18:24:40.681Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"c2fae93dc60a82b5cd5a492914b33281c1628c952fec67204c9048fb2837a5ce","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C7957"},{"id":"ea4ce265-f58b-4d76-abf7-234e46b1e693","kind":"institutions","code":"UB-I880","name":"Dachencaizhi","nameBasis":"transliterated","summary":"Leading local Chinese venture capital firm.","description":"Leading local Chinese venture capital firm.","country":null,"category":null,"originalName":"达晨财智","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:19.702Z","englishUpdatedAt":"2026-10-15T18:45:27.898Z","reviewedAt":"2026-10-15T18:45:27.898Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2c9470e41eb05e4887a285a13f7e0500c4f7810d3755d3475938a3e6efb3d03f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/dachencaizhi"},{"id":"a7331e6f-31b6-41e9-be3c-084ebe9d9fe7","kind":"institutions","code":"UB-I019","name":"Gaorong Capital","nameBasis":"transliterated","summary":"An emerging venture capital firm covering TMT, AI, and consumer investments, with notable investments including Pinduoduo, Huya, and Mogujie.","description":"An emerging venture capital firm covering TMT, AI, and consumer investments, with notable investments including Pinduoduo, Huya, and Mogujie.","country":null,"category":null,"originalName":"高榕资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.139Z","englishUpdatedAt":"2026-10-15T21:41:18.630Z","reviewedAt":"2026-10-15T21:41:18.630Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7fa0e7e315ae3d1e83bdb160363ee12e882a601a724f02ad3a4d9678209fabc7","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaorong-capital"},{"id":"f2ef658d-89f2-41cc-855e-6f8038fb017b","kind":"institutions","code":"UB-I8117","name":"Guoke","nameBasis":"transliterated","summary":"Guoke, an investment guidance fund backed by government or state-owned capital.","description":"Guoke, an investment guidance fund backed by government or state-owned capital.","country":null,"category":null,"originalName":"国科","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:26:13.640Z","englishUpdatedAt":"2026-10-15T17:35:39.989Z","reviewedAt":"2026-10-15T17:35:39.989Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d4efb87064ff34cad92c345d0ebfc50e9637c5c134f8d1784259f4fd2419b0d2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/guoke"},{"id":"fe4edfc7-e1c4-4ccb-9b50-80b8c8054d5c","kind":"institutions","code":"UB-I8085","name":"Shanghai Biotechnology Pharmaceutical Innovation Zhuanhua Fund","nameBasis":"transliterated","summary":"Shanghai Biomedical Innovation and Commercialization Fund, an industrial investment fund focused on healthcare.","description":"Shanghai Biomedical Innovation and Commercialization Fund, an industrial investment fund focused on healthcare.","country":null,"category":null,"originalName":"上海生物医药创新转化基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:26:13.527Z","englishUpdatedAt":"2026-10-15T21:21:01.815Z","reviewedAt":"2026-10-15T21:21:01.815Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fa5f22bbe09dc9a15b20549b1ca18708f6276706b90e75ee5ae4005c599a3011","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/shanghai-biotechnology-pharmaceutical-innovation-zhuanhua-fund"},{"id":"7bd6c144-34fb-4feb-94e3-591aff8676cc","kind":"institutions","code":"UB-I241","name":"Xinglian Capital","nameBasis":"transliterated","summary":"Xinglian Capital is a mainland Chinese venture capital firm, focused on early-stage innovation projects.","description":"Xinglian Capital is a mainland Chinese venture capital firm, focused on early-stage innovation projects.","country":null,"category":null,"originalName":"星连资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:25.917Z","englishUpdatedAt":"2026-10-15T18:21:17.137Z","reviewedAt":"2026-10-15T18:21:17.137Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"414cdad9d1b081902c19175c889898b974a1bdb5e6794769416bd18fda08255a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/xinglian-capital"},{"id":"47bfa5c3-6204-4379-9711-8ad83d4d66a8","kind":"institutions","code":"UB-I8037","name":"Zhishu Capital","nameBasis":"transliterated","summary":"Zhishu Capital, a financial advisory services firm.","description":"Zhishu Capital, a financial advisory services firm.","country":null,"category":null,"originalName":"指数资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:26:13.333Z","englishUpdatedAt":"2026-10-15T20:27:18.702Z","reviewedAt":"2026-10-15T20:27:18.702Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2b29aa0ce89908aa79d6662acc8891a8cbe34a2a9042cfd1defa44e677f6d4ae","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/zhishu-capital"}],"path":"/news/33bbbf29-0962-43e6-99b5-dd31f1b37095","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"BioGeometry","path":"/companies/UB-C7957"}},"canonical":"https://uniquebase.ai/news/33bbbf29-0962-43e6-99b5-dd31f1b37095"}